Illness	Number of cases
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	341
Malignant neoplasm of prostate (C61)	265
Hyperplasia of prostate (N40)	246
Calculus of kidney and ureter - Calculus of ureter (N20.1)	149
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	147
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	126
Unspecified haematuria (R31)	111
Calculus of kidney and ureter - Calculus of kidney (N20.0)	86
Obstructive and reflux uropathy (N13.3)	68
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	62

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.1)	2.048
Injection or administration of medicines into the urinary bladder (8-132.x)	2.013
Examination of the urethra and the urinary bladder by endoscopy (1-661)	1.299
(1-999.40)	1.142
Injection or administration of medicines into the urinary bladder (8-132.3)	787
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	677
Insertion, exchange or removal of a ureteral stent (8-137.00)	446
Examination of the ureter by endoscopy (1-665)	360
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	276
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	217

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ05

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
176	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
106	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
103	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at universities of applied sciences
Doctoral supervision
Project-related cooperation with colleges and universities
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies
Initiation and management of uni-centric/multi-centric clinical/scientific studies

Training

No.	Training in other healing professions	Comment
HB20	Nursing professional B. Sc.
HB15	Anaesthesia technical assistant (m/f)
HB19	Nursing professionals
HB17	Auxiliary nurse (m/f)
HB05	Medical technical radiology assistant (MTRA) (m/f)
HB10	Midwife (m/f)
HB07	Surgical technical assistant (m/f)
HB12	Medical technical laboratory assistant (MTLA) (m/f)
HB01	Nurse and health care worker (m/f)